Recombinant activated factor VII treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, and efficacy and safety outcomes

Míreanna Comhchosúla

• Recombinant activated factor VII for the treatment of bleeding in abdominal surgery and cardiac surgery
  le: Michalska, G, et al.
  Foilsithe: (2009)
• Use of Activated Recombinant Factor VII in Severe Bleeding – Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding
  le: lau, Philip, et al.
  Foilsithe: (2012)
• Efficacy of recombinant activated factor VII in the management of severe hemorrhage following cardiac surgery
  le: Trecova, N, et al.
  Foilsithe: (2006)
• Factor VII for intractable bleeding after cardiac surgery
  le: Kogan, A, et al.
  Foilsithe: (2007)
• Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
  le: Shulutko, E, et al.
  Foilsithe: (2006)